The present method for the measurement of 24,25dihydroxyvi-tamin D (24,25-(0H) One of the polar metabolites of 25-hydroxyvitamin D3 (25-(OH)D3), namely 24,25-dihydroxyvitamin DQ (24,25-(OH)zD3) was first identified in 1973 (5). This metabolite is quantitatively the main 25-(OH)D3 dihydroxyderivative found in the serum of normal animals (1, 3) and of normal human subjects (6). Its significance in vitamin D physiology is not clear (2, 3) . Methods for the measurement of 24,25-(0H)zD concentrations in human serum have been recently developed (4, 8, 1Cb12). The data obtained with these technics may help for a better understanding of the role of this metabolite. Results published so far concern mainly adults and, to our knowledge, only one investigation on serum 24,25-(OH)zD3 concentrations in neonates, children, and adolescents, has been reported (I I). In 1976, an assay for 24,25-(0H)zD measurement in lipid extracts of serum was developed in our laboratory. It includes a chromatography on Sephadex LH 20 column, a further purification step using a high pressure liquid chromatographic system and a competitive protein binding assay.
24,25-(OH)zD serum concentration increased after vitamin D administration, yet it was not found higher in a Iwk-old child with vitamin Dz intoxication (25-(0H)D: 900 ng/ml, 24,25-(0H)zD: 6 ng/ml) than in three children with vitamin D deficiency rickets in the 2nd wk after administration of vitamin Dz and calcium (25-(0H)D: 25.5 f 9.2 ng/ml, 24,25-(OH)zD: 13.4 + 3.7 ng/ml, 2) In a child with pseudodeficiency rickets, 24,25-(0H)zD concentrations were found elevated before treatment. They decreased to normal values during treatment with la-(OH) cholecalciferol, whereas 25-(0H)D concentrations were not significantly different before and after treatment.
Speculation
Development of methods for the measurement of 24,25-(OH)zD concentration in serum should provide valuable informations for a better understanding of vitamin D metabolism in physiologic and pathologic states in children.
One of the polar metabolites of 25-hydroxyvitamin D3 (25-(OH)D3), namely 24,25-dihydroxyvitamin DQ (24,25-(OH)zD3) was first identified in 1973 (5). This metabolite is quantitatively the main 25-(OH)D3 dihydroxyderivative found in the serum of normal animals (1, 3) and of normal human subjects (6) . Its significance in vitamin D physiology is not clear (2, 3) . Methods for the measurement of 24,25-(0H)zD concentrations in human serum have been recently developed (4, 8, 1Cb12) . The data obtained with these technics may help for a better understanding of the role of this metabolite. Results published so far concern mainly adults and, to our knowledge, only one investigation on serum 24,25-(OH)zD3 concentrations in neonates, children, and adolescents, has been reported (I I). In 1976, an assay for 24,25-(0H)zD measurement in lipid extracts of serum was developed in our laboratory. It includes a chromatography on Sephadex LH 20 column, a further purification step using a high pressure liquid chromatographic system and a competitive protein binding assay.
The present paper describes the method of 24.25-(0H)zD measurement in serum and reports the results obtained in normal children as compared to normal adults; in children with vitamin D deficiency or vitamin D resistant rickets; and in one child intoxicated with ergocalciferol.
MATERIAL AND METHODS

VITAMIN D METABOLITES
[ 2 6 , 2 7 -'~] 2 5 -( 0~)~' was purchased from the radiochemical Centre Amersham, Buckinghamshire, England (specific activity 1 1.7 or 12.1 Ci/mmole).
[26,27-3H]24,25-(OH)2D3 was obtained from in vitro incubations of prepubertal rabbit kidney homogenates with tritiated 25-(OH)D', using the technique described for the production of 1,25-(OH)zD3 in chick kidney homogenates (7) . After methanol-chloroform extraction of the kidney tissue, the chloroform phase was chromatographed on a 2 x 60 cm Sephadex LH 20 column equilibrated with chloroform-hexane 65:35 (v/v). 24,25-(OH)zD3 was then chromatographed on a high pressure liquid chromatograph as described later in this paper. Periodate sensitivity of "H-24,25-(OH)zD3 was verified before its use.
25-(OH)D3 was a gift from Roussel Laboratory, Paris, France and 24R,25-(OH)zD3 a gift from Dr. Uskokovic, Hoffman-La Roche, Nutley, New Jersey. Both vitamin D metabolites were stored at -20°C in ethanol.
BINDING PROTEIN
Weanling rats were kept in a dark room and raised on a vitamin D deficient diet containing 0.47% calcium and 0.3% phosphorus. After 4-6 wk, rats were sacrificed by decapitation, the serum was collected and frozen in 10 pl aliquots at -20°C. A 1/20.000 (v/v) solution of this D-deficient rats serum in barbital acetate buffer pH 8.6 was used for the assays (9).
SERA EXTRACTION AND CHROMATOGRAPHY
Five hundred dpm of %-25-(0H)D' and 500 dpm of "H-24.25-(OH)zD3 were added to 2 ml of serum samples before their extraction. After Yz hr at room temperature, chloroform-methanol extraction was performed as described by Preece et al. (9) . The lipid extract was dissolved in 0.3 ml of 5050 chloroform-n hexane and chromatographed on a Sephadex LH 20 column 185 x 5 mm equilibrated with the same solvent mixture. Thirty fractions of 1 ml were collected. A 0.2 ml aliquot of each fraction was dried down and the radioactivity counted in 10 ml of counting solution (5 g of PPO and 0.1 g of dimethyl POPOP/liter of toluene). Fractions in the '~-25-(0H)D' region (2-5 ml) and in the 'H-24,25-(OH)2D3 region (7-13 ml) were pooled separately and dried down. The fraction containing 25-(OH)D3 was applied on a silicic acid column to separate 25-(OH)D3 from vitamin D and from metabolites less polar than 25-(0H)D' (9) . The 24,25-(0H)zD' fraction was dissolved in 0.1 ml ethanol and injected in a high pressure chromatograph (Waters Associates, Milford, Massachu-NGUYEI setts 01757, USA) equipped with a solvent delivery system model 6000 A and a sample injector model V6K, fitted with a 4'mm I.D. X 30 cm ~Bondapak Cia column. A linear gradient from 50-100% methanol in water was used as solvent (2.5% v/v per min) with a flow rate of 3 ml/min. Six ml fractions of the effluent were collected. An aliquot (0.5 ml) of each fraction was counted in 10 ml Instagel solution. The 24,25-(OH)2D3 region from high pressure liquid chromatography and the 25-(OH)D3 region from silicic acid chromatography were dried down and dissolved in 2 ml ethanol. An aliquot of each of the final solutions was counted in order to measure the total recovery after the extraction and chromatographic procedures. Recovery was calculated as the ratio of the radioactivity present in the 2 ml ethanol solution, to the radioactivity added to the serum sample before the extraction. Mean percent of recovery for the dosages of 78 different blood samples 
25-(0H)D COMPETITIVE BINDING ASSAY
25-(0H)D concentration was estimated with the assay described by Preece et al. (9) . The high sensitivity of this assay allows the measurement of 25-(0H)D concentrations as low as 0.5 ng/ml of serum (0.02 pmole per incubation tube).
24,25-(OH)~D COMPETITIVE BINDING ASSAY
It has been shown that 24,25-(OH)2D3 has the same affinity as 25-(OH)D3 for the 25-(0H)D rat serum binding protein (4, 8, 10 , I I). In our hands also, synthetic 24,25-(OH)2D3 was found as effective as 25-(OH)D3 in displacing "H-25-(OH)D3 from its binding to the D-deficient rat serum protein. The 24,25-(OH)2D concentration in serum was therefore measured with the 25-(0H)D competitive binding assay system i.e., using as a standard curve, the displacement of " H -~~-( o H ) D~.
One serum was extracted ten times and each of the ten extractions was assayed twice for vitamin D metabolites. Within assay variations were, respectively, 9.3% for 25-(0H)D (1 1.8 f 1.1 ng/ ml) and 10.4% for 24.25-(0H)zD (2.6 + 0.27 ng/ml).
RESULTS
NORMAL SUBJECTS
Serum 25-(0H)D and 24,25-(OH)2D concentrations were measured in 5 neonates, 16 children, and 10 adolescents with no alteration in phosphorus and/or calcium metabolism and no known renal, intestinal, or endocrine diseases. The values observed in these young subjects were compared to those found in 14 normal adults, aged 18-50 yr (Table 1 ). All samples were collected randomly throughout the year 1976.
In normal adults, serum concentrations of 25-(0H)D and 24,25-(OH)2D (mean f 1 SD) were 20 f 7.4 and 1.4 f 0.8 ng/rnl, respectively. The concentrations of these metabolites (mean f 1 SD) in children and adolescents were not significantly different from the values found in adults. In the five neonates studied before the 6th day of life neither 25-(0H)D concentrations nor 24,25-(0H)zD concentrations were statistically different from the values found in older children or in adults.
When all the data were pooled and analyzed according to the seasonal period of sampling (Table I) , lower concentraGons of serum 25-(0H)D were noted during the winter and spring 1976. These low concentrations in serum 25-(0H)D were associated with higher concentrations of 24,25-(OH)2D. However, none of these differences are statistically significant, presumably because of the small number of subjects studied in each season.
The analysis of the 25-(0H)D and 24,25-(0H)zD serum values for the whole group of normal subjects studied did not demonstrate a positive correlation between serum concentrations of 24,25-(OH)2D and 25-(0H)D (Fig. 1) . It is to be noted that the seven highest values of 24,25-(OH),D serum concentrations were found in subjects with low 25-(0H)D serum concentrations (lower or equal to 12 ng/ml).
VITAMIN D-DEFICIENCY RICKETS
Serum 25-(0H)D and 24,25-(0H)zD concentrations were measured in three children (aged 14-18 months) with overt radiologic signs of rickets increased serum alkaline phosphatase activities (respectively, 2470, 1850, and 1000 mU/ml of serum with normal values from 112-696 mU/ml), low serum calcium concentrations (respectively, 8.0, 7.8, and 8.8 mg/100 ml) and low serum phosphorus concentrations (respectively, 4.0, 3.1, and 2.7 mg/100 ml). Blood samples for vitamin D measurements could only be obtained after 1 wk of hospitalisation and after the start of oral calcium supplementation (1 80-360 mg/d). At that time, 25-(0H)D and 24,25-(OH)2D concentrations were low, but not significantly different from the values found in normal children (Table 2) . During the first 2 weeks after one im injection of 5 mg of vitamin D2, the measurement of vitamin D metabolites showed a slight increase (basal value x 2.6) in serum 25-(0H)D concentration contrasting with a rapid and marked increase (basal value x 33) in 24,25-(OH)2D concentration. The ratio of serum 24,25-(OH)2D/ over a period of 4 yr and 6 months (Fig. 2) Table 3 shows the data concerning three children with "pseudodeficiency rickets" aged 11-16 yr, three subjects with hereditary hypophosphatemia aged 3-13 yr, and one patient with a vitamin D resistant rickets associated with Recklinghausen's neurofibromatosis. Pretreatment levels of 25-(0H)D and 24,25-(OH)ZD could be measured for three patients. The presence of 24,25-(0H)zD was detected in the serum of the three patients (two with pseudodeficiency rickets and one with hereditary hypophosphatemia). After 3 months to 5 yr of oral 25-(OH)D3 administration serum 25-(0H)D concentrations were elevated in all patients. In contrast, serum 24,25-(OH)zD concentrations were high in only three subjects (Table 3 , patients K.A., S.K., and L.A.). These high values of 24,25-(0H)zD were associated with the highest values of 25-(0H)D observed in this study, in two patients. In the third patient, it was associated with a moderately increased concentration of 25-(OH)D, i.e., 98 ng/ml. No correlation was found between serum 24,25-(OH)2D concentrations and serum calcium and phosphorus concentrations (Table 3 ).
In a fourth child with pseudo-deficiency rickets, 25-(0H)D and 24,25-(OH)zD serum concentrations were measured, before and during treatment with la-hydroxycholecalciferol (la-(OH)D3), The present method associates a highly sensitive assay (9) and a double step chromatography of the serum. The Sephadex LH 20 plus high pressure liquid chromatography system was aimed to avoid contamination of the 24,25-(OH)2D fraction by other vi- Table 2 ' Mean + I SD of values measured in six blood samples (two samples for each child).
:' Mean f I SD of values measured in three blood samples (one sample for each child). (4) .
Our values in normal children are not significantly different from those found in normal adults. At the present time, there is only one report of serum 24,25-(0H)zD concentrations in children. 
